Moreover, research underscores the significant influence of downregulated IGF-1 and GLP-1 signaling pathways on ALS progression, with dysregulation of these pathways contributing to neurodegeneration. This evidence concerns the gene GLP1R and amyotrophic lateral sclerosis.